Skip to main content
Earnings Labs
TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc. (TCRX)

NASDAQ·Healthcare·Biotechnology

$0.36

+2.23%

Mkt Cap $19.05M

Analyst Ratings

Buy

3

Hold

3

Sell

0

Price Target (2 analysts)

$7.50

Range $3.00$12.00

Implied Upside

+1967.8%

Consensus $7.50 vs current $0.36